BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Chronic hepatitis C
1
Baseline and longitudinal biomarkers predict hepatocellular carcinoma in chronic hepatitis C: A cohort study
5/14/2026 9:17:09 AM | Browse: 1 | Download: 0
2
Non-invasive prediction of significant hepatic fibrosis in individuals with chronic hepatitis C infection using fibrosis risk score and machine learning models
3/26/2026 9:22:59 AM | Browse: 20 | Download: 69
3
Sex-related differences in treatment outcomes of chronic hepatitis C with direct-acting antivirals
10/27/2025 10:57:49 AM | Browse: 233 | Download: 376
4
Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
9/25/2025 11:24:03 AM | Browse: 163 | Download: 416
5
Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease
8/27/2025 9:21:09 AM | Browse: 225 | Download: 514
6
Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs
6/26/2025 7:27:55 AM | Browse: 190 | Download: 707
7
Transient elastography and diffusion-weighted magnetic resonance imaging for assessment of liver fibrosis in children with chronic hepatitis C
8/29/2024 7:51:41 AM | Browse: 187 | Download: 883
8
Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
3/27/2024 1:28:19 PM | Browse: 222 | Download: 757
9
Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019)
3/11/2024 2:44:49 PM | Browse: 346 | Download: 1180
10
Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study
2/4/2024 10:57:42 AM | Browse: 389 | Download: 1518
11
Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
11/24/2023 6:10:12 AM | Browse: 361 | Download: 1412
12
Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
11/24/2023 6:10:11 AM | Browse: 511 | Download: 1211
13
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 380 | Download: 1223
14
Sarcopenia in chronic viral hepatitis: From concept to clinical relevance
5/24/2023 9:31:05 AM | Browse: 424 | Download: 1147
15
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C
2/10/2023 9:15:29 AM | Browse: 478 | Download: 1160
16
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
6/9/2022 7:17:55 AM | Browse: 742 | Download: 2452
17
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
1/21/2022 8:16:14 AM | Browse: 735 | Download: 1885
18
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
11/10/2021 7:13:09 AM | Browse: 991 | Download: 1725
19
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
5/14/2021 10:27:31 AM | Browse: 868 | Download: 1983
20
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
5/10/2021 7:46:10 AM | Browse: 678 | Download: 2004
21
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
4/29/2021 2:12:02 AM | Browse: 744 | Download: 1739
22
Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
2/25/2021 3:45:30 PM | Browse: 1093 | Download: 2578
23
Management of hepatitis C in children and adolescents during COVID-19 pandemic
8/25/2020 9:16:00 AM | Browse: 963 | Download: 1952
24
Liver-related effects of chronic hepatitis C antiviral treatment
6/14/2020 1:45:26 PM | Browse: 1205 | Download: 2295
25
Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus
4/23/2020 10:34:55 AM | Browse: 816 | Download: 2531
26
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 1428 | Download: 2251
27
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
8/26/2019 2:56:47 AM | Browse: 1071 | Download: 3169
28
High prevalence of occult hepatitis C infection in predialysis patients
1/27/2019 7:04:05 AM | Browse: 1071 | Download: 2432
29
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 950 | Download: 1733
30
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
3/26/2018 8:48:04 AM | Browse: 1523 | Download: 3540
31
Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
1/26/2018 8:09:36 AM | Browse: 1410 | Download: 2344
32
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1384 | Download: 2844
33
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
7/7/2017 11:41:16 AM | Browse: 1273 | Download: 2821
34
Interferon related pericarditis: Review
6/26/2017 12:49:43 AM | Browse: 1350 | Download: 1935
35
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
6/14/2017 9:25:57 AM | Browse: 1340 | Download: 2859
36
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 2169 | Download: 4301
37
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 1649 | Download: 2872
38
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
4/6/2017 6:30:00 PM | Browse: 1477 | Download: 2454
39
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
2/27/2017 8:50:00 AM | Browse: 1413 | Download: 2409
40
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 1403 | Download: 2261
41
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
11/26/2016 6:56:00 PM | Browse: 1442 | Download: 3246
42
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
11/6/2016 3:43:00 PM | Browse: 1144 | Download: 1950
43
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
10/14/2016 1:37:00 PM | Browse: 1441 | Download: 2092
44
Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
9/30/2016 5:59:00 PM | Browse: 1427 | Download: 3029
45
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
9/4/2016 2:49:00 PM | Browse: 1618 | Download: 2631
46
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles
7/29/2016 8:32:00 PM | Browse: 1395 | Download: 2478
47
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
4/19/2016 9:45:00 AM | Browse: 1477 | Download: 3480
48
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
3/23/2016 4:26:00 PM | Browse: 1614 | Download: 2933
49
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage
1/20/2016 5:04:00 PM | Browse: 1502 | Download: 2076
50
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver
12/10/2015 10:35:00 AM | Browse: 1321 | Download: 1922
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.